Regulation of physician associates raises concerns

In a landmark case, The British Medical Association, R (on the application of) v General Medical Council, determined key issues regarding the regulatory framework for physician associates (PAs) and anaesthesia associates (AAs) in the UK. The ruling, issued on 17 April 2025, followed the General Medical Council’s (GMC) expanded authority under the Anaesthesia Associates and Physician Associates Order 2024, which allowed it to regulate these professional roles alongside traditional medical doctors.

The case centred on two principal objections raised by the British Medical Association (BMA). Firstly, the BMA challenged the GMC’s terminology of "medical professionals" to describe both doctors and associates. The BMA asserted that this definition muddied critical differences in roles and responsibilities between qualified doctors and their non-medically qualified counterparts, which could confuse patients regarding the nature of their care.

Secondly, the BMA contested the GMC’s application of a shared professional standards framework called Good Medical Practice (GMP) across both groups. The BMA argued that this approach undermined the unique qualifications and training of doctors, while posing essential risks to public safety. The absence of a universally accepted practice scope for PAs and AAs heightened concerns that overlapping standards might mislead patients and compromise care quality.

The court ruling underscored the increasing presence of PAs and AAs in the healthcare workforce, which has expanded since their introduction in 2003 and 2004. These associates perform various clinical tasks under supervision, but their educational backgrounds significantly differ from that of medical doctors, necessitating clear regulatory standards.

Evidence presented during the case revealed concerning instances of patient confusion and potential risks due to misunderstandings about associate roles. Patients sometimes did not realise they were being treated by individuals lacking medical qualifications, leading to unacceptable health outcomes. The BMA argued that clear distinctions between the roles were essential to safeguard patients and maintain trust in the healthcare system.

Ultimately, the court upheld the GMC’s authority to regulate doctors and associates under a shared set of professional standards, emphasising that this unified approach aimed to ensure adherence to high standards of care across the board. The decision indicated that the GMC had engaged in thorough consultations with stakeholders, showcasing robust support for shared professional standards.

The ruling concluded that the term "medical professionals" served an administrative function and did not mislead the public significantly. In addition, the court dismissed claims of irrationality in the GMC’s decisions regarding the categorisation of associate roles. Importantly, it affirmed that while associates have distinct functions, the regulatory overlap justified a uniformity that could enhance the overall quality of patient care.

This judgement reflects the delicate balance between effective regulation and the changing landscape of healthcare professions, highlighting an ongoing discussion about the roles and expectations of both physicians and their associates. As the healthcare sector continues to evolve, it remains imperative to clarify distinctions within roles while prioritising patient safety in all regulatory frameworks. The outcomes from this legal context are expected to influence future policies concerning the training, professional practice, and public perception of physician associates and anaesthesia associates throughout the UK.